Dear Editor,
We present a case of hypermetropic amblyopia in type II Waardenburg syndrome (WS) to highlight the association. WS is an “oculo-dermato-auditif” dysplasia described in 1947 by Waardenburg and by Klein in 1950. It is distributed worldwide, with no predilection for race or gender. The prevalence is estimated to be 1:42 000 live births in the general population[1]–[2]. WS is a genetic disease with autosomal dominant transmission with incomplete penetrance and variable expressivity. Complex network of interaction between six genes have been identified to date. They are PAX3 gene, primarily responsible for type I and III WS; MITF, SOX10, and SNAI2 genes in type II WS; EDN3 and EDNRB genes in type IV WS[1]–[4].
Patients living with WS can present with telecanthus, broad nasal root, synophrys of eyebrows, white forelock, heterochromia iridis and deaf-mutism. WS is classified into 4 types. Type I presents the full symptomatology with canthorum dystopia while type II has no canthorum dystopia. Type III WS includes type I WS with musculoskeletal abnormalities or ortho-osteo-myo-dysplasia of the upper limbs. Type IV WS (Shah-Waardenburg syndrome) includes type I WS with congenital megacolon[1]–[2],[4].
The diagnostic criteria for WS have been proposed by the Waardenburg Consortium in Table 1. It includes at least 2 major criteria or 1 major plus 2 minor criteria. The categorization of WS (I to IV) can be established by clinical features. Molecular genetic analysis can aid in the diagnosis if the clinical features are inconclusive. Our patient has 2 major criteria met without canthorum dystopia and hence classified as type II WS[1]–[2],[4]. We obtained the written informed consent from the patient's parent, and this case study is in accordance with the tenets of the Declaration of Helsinki.
Table 1. Diagnostic criteria for Waardenburg syndrome[1],[5].
| Rank | Criteria |
| Major | Congenital sensorineural hearing loss White forelock, hair hypopigmentation Iris pigmentation abnormality: complete heterochromia iridum, segmental heterochromia, or complete hypoplastic blue iridis (brilliant blue iridis) Dystopia canthorum, aW index>1.95 Affected first-degree relative |
| Minor | Skin hypopigmentation (congenital leukoderma) Synophrys/medial eyebrow flare Broad high nasal root, prominent columella Hypoplastic nasal alae Premature gray hair (age<30y) |
aW index, W=X+Y+a/b. The measurements necessary to calculate the W index (in millimeters) are: inner canthal distance (a), interpupillary distance (b), and outer canthal distance (c). X=[2a-(0.2119c+3.909)]/c. Y=[2a-(0.2479b+3.909]/b.
This is a returned case of 11-year-old girl diagnosed with type II WS since the age of five months with bilateral sensorineural hearing loss, heterochromia iridis and a family history of deafness. She underwent a cochlear transplant at three years old. She had her first ophthalmology assessment at three years old with an objective refractive assessment documented as bilateral best corrected visual acuity (BCVA) of 20/30 and hypermetropia of +3.00 spherical diopter (+3.00 D).
However, she defaulted the ophthalmology follow up until she presented again at the age of 11 years old complaining of bilateral suboptimal vision. A detailed ophthalmic examination revealed both eyes hypermetropic amblyopia with right eye BCVA 20/40, +3.75 D and left eye BCVA 20/40, +3.50 D. Anterior segment examination revealed heterochromia iridis with right eye hypochromia as previously documented (Figure 1). Dilated fundus examination showed bilateral mixed hypo- and hyperpigmentation of the fovea and peripheral retina (Figure 2A, 2B). Other examinations were unremarkable. There was no other feature of WS such as white forelock or telecanthus. She had no squint, anisocoria or reactive afferent pupillary defect. The optic discs were pink with cup-to-disc ratio of 0.3. She was prescribed with glasses with regular follow up for reassessment.
Figure 1. Heterochromic iridis with right eye hypochromia, absent of white forelock.

Figure 2. Pigmentary changes.

A, B: Fundus photo showed bilateral mixed hypo- and hyperpigmentary changes of the fovea at 11 years old; C, D: Collage fundus photo showed bilateral eyes with increased pigmentary changes of the fovea and peripheral retina after 3y of follow up.
Her BCVA remained 20/40 in the right eye and 20/60 in the left eye after 3y of follow up. There was no other new ocular finding except some further pigmentary changes in the peripheral retina (Figure 2C, 2D).
Literature search with the words “Waardenburg syndrome” AND “amblyopia” and its related terms using PubMed Medline, EBSCOhost Medline, and Scopus databases revealed seven reports with total of 12 cases, which are summarized in Table 2[1],[3],[5]–[7].
Table 2. Summary of systematic literature review.
| Literature | Total No. of WS cases | No. of cases with amblyopia | Amblyopia cases | Refractive status and visual acuity of amblyopic eye (s) |
Other ocular findings | |
| Right eye (OD) | Left eye (OS) | |||||
| Akal et al[5], 2013 | 1 | 1 | 8y/male hyperopic amblyopia |
BCVA 1.0 +5.00 D |
BCVA 0.3 +6.50 D |
OD: Segmental heterochromia. Fundus unremarkable OS: Complete heterochromia. Fundus unremarkable |
| Ohno et al[3], 2003 | 11 | 2 | 18y/female hyperopic amblyopia |
BCVA 0.9 | BCVA 1.2 | OD: Segmental heterochromia. Fundus hypopigmentation in upper temporal periphery OS: Complete heterochromia. Fundus total hypopigmentation |
| 15y/female hyperopic amblyopia | BCVA 1.0 | BCVA 0.7 | OD: Complete heterochromia. Fundus total hypopigmentation OS: Segmental heterochromia. Fundus total hypopigmentation |
|||
| Bard[6], 1978 | 7 | 4 | 12y/female hyperopic amblyopia |
BCVA 20/30 +2.25 D |
BCVA 20/40 +3.75 D |
OD: No iris hypopigmentation. Fundus segmental hypopigmentation OS: Segmental heterochromia. Fundus more segmental hypopigmentation compare to right eye |
| 10y/female hyperopic amblyopia |
BCVA 20/40 +4.50 D |
BCVA 20/30 +4.62 D |
OD: No iris hypopigmentation. Fundus peripheral hypopigmentation OS: Segmental heterochromia. Fundus more peripheral hypopigmentation compare to right eye |
|||
| 7y/female hyperopic amblyopia |
BCVA 20/40 +3.00 D |
BCVA 20/50 +3.25 D |
Both eyes: Complete heterochromia. Fundus albinotic |
|||
| 7y/male hyperopic amblyopia |
BCVA 20/30 +1.50 D |
BCVA 20/200 +7.00 D |
OD: Segmental heterochromia. Fundus macula albinotic, segmental hypopigmentation and white spots OS: Segmental heterochromia. Fundus mottled yellow maculae, segmental hypopigmentation and tilted disc |
|||
| Li et al[7], 2019 | Total 90. 57 are type 2 WS |
1 | NA | NA | Iris heterochromia. | |
| Albarry et al[1], 2019 | 11 | 4 | 58y/male amblyopia |
BCVA 0.9 | BCVA 0.7 | Both eyes heterochromia. Fundus hypopigmentation |
| 16y/male amblyopia |
BCVA 0.6 | BCVA 0.4 | OD: No abnormality OS: Segmental heterochromia. Fundus generalised hypopigmentation |
|||
| 28y/female amblyopia |
BCVA 0.8 | BCVA 0.7 | OD: Segmental heterochromia. Fundus no hypopigmentation OS: Segmental heterochromia. Fundus generalised hypopigmentation |
|||
| 25y/female esotropia amblyopia |
NA due to mentally retard | NA due to mentally retard | Both eyes no abnormality | |||
BCVA: Best corrected visual acuity; NA: Not available.
Akal et al[5] reported a case of type II WS with anisometropic amblyopia. Reported case had left eye hypermetropia with BCVA 0.3. After occlusion therapy for amblyopia, the left eye BCVA improved to 0.4. The author drew attention for detailed ophthalmology examination in type II WS and amblyopia should be investigated, to avoid delay in diagnosis and treatment of additional pathologies.
Ohno et al[3] reported a cases series involving 11 patients with type II WS and only two patient had a unilateral hypermetropic amblyopia. The rest of the patients had no poor vision or visual field defects.
Albarry et al[1] studied a Saudi family with eleven members diagnosed with type II WS. Two of the family members had bilateral amblyopia and another two of the family members had unilateral amblyopia. They postulated that amblyopia is related to hypopigmentation of the fundus in the four families as there were no other fundus abnormalities found.
Similar to Sharma and Arora's[4] report, the author reported two cases of type II WS. One of the patients had amblyopia and the author also associated the amblyopia to the fundus depigmentation.
Cortés-González et al[8] studied two unrelated families with WS. The author reported that among all type II WS patients, one had bilateral reduced anteroposterior axial length (AP-AXL) and a high hypermetropic refractive error corresponding to posterior microphthalmos. The author also reported in the first family, there were 3 patients with hypermetropia and 2 of them had reduced AP-AXL; and in the second family, one patient had hypermetropia with reduced AP-AXL. However, the visual acuities were not reported.
Read and Newton[2] showed that there is an association between mutation of the MITF gene with microphthalmia in type II WS. The author explained that MITF gene, the human homologues of the mouse microphthalmia gene is mapped to the same location. This explained the association of hypermetropic refractive error with reduced AP-AXL in Vianney's report.
Falzon et al[9] reported that 42% of 141 children who had undergone cochlear implant had ocular abnormalities with refractive errors. Hypermetropia was the most common refractive error (15%) and one of the children was diagnosed with WS.
Refractive error and amblyopia are not typically present in WS and are not included in the latest diagnostic criteria of the disease. However, our literature review revealed 12 cases of amblyopia and 7 of them were related to refractive error and all of the 7 cases were hypermetropia. The hypermetropic power ranged from +2.25 D to +6.50 D. None of the reports documented repeated refraction. We believe the true incidence of hypermetropic amblyopia is unknown due to the lack of formal and serial refractive assessment in the previous reports.
There were other causes of amblyopia reported from the literature review. Three cases were postulated that amblyopia is related to hypopigmentation of fundus. Six out of 7 cases reported of hypermetropic amblyopia had hypopigmented fundus as well. The remaining 2 cases did not explain the cause of amblyopia. Our patient does have macula hypopigmentation as well. However, patient with hypopigmentation of retinal pigment epithelium without macular hypoplasia may not related to reduced visual acuity[3].
Our case report revealed an interesting finding of persistent hypermetropia that documented from age of 3 to 11. None of the previous reported cases documented this persistent hypermetropia. The failure of emmetropization showed in this case can be related to the underlying genetic problem in WS. The underlying deranged melanocytic-pigmentary system in WS may lead to disruption of normal emmetropization as suggested by previous studies on ocular albinism[2],[6], which leads them to the risk of persistent hypermetropia and subsequently development of amblyopia if untreated.
Refractive hypermetropia is well known to cause amblyopia, but an association between WS and refractive amblyopia due to failure of emmetropization has not been made. This might draw the attention of eye care providers to this association and to be aware that detailed ophthalmic and refractive examinations in patients with WS may prevent refractive amblyopia.
Acknowledgments
Conflicts of Interest: Chua SW, None; Mohd Khialdin S, None; Mustapha M, None; Md Din N, None; Yong MH, None.
REFERENCES
- 1.Albarry MA, Alreheli AQ, Albalawi AM, Basit S. Whole genome genotyping mapped regions on chromosome 2 and 18 in a family segregating Waardenburg syndrome type II. Saudi J Ophthalmol. 2019;33(4):326–331. doi: 10.1016/j.sjopt.2019.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Read AP, Newton VE. Waardenburg syndrome. J Med Genet. 1997;34(8):656–665. doi: 10.1136/jmg.34.8.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ohno N, Kiyosawa M, Mori H, Wang WF, Takase H, Mochizuki M. Clinical findings in Japanese patients with Waardenburg syndrome type 2. Jpn J Ophthalmol. 2003;47(1):77–84. doi: 10.1016/s0021-5155(02)00629-9. [DOI] [PubMed] [Google Scholar]
- 4.Sharma K, Arora A. Waardenburg syndrome: a case study of two patients. Indian J Otolaryngol Head Neck Surg. 2015;67(3):324–328. doi: 10.1007/s12070-015-0870-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Akal A, Göncü T, Boyaci N, Yılmaz ÖF. Anisometropic amblyopia in a case of type 2 Waardenburg syndrome. BMJ Case Rep. 2013;2013:bcr2013201140. doi: 10.1136/bcr-2013-201140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bard LA. Heterogeneity in Waardenburg's syndrome. report of a family with ocular albinism. Arch Ophthalmol. 1978;96(7):1193–1198. doi: 10.1001/archopht.1978.03910060027006. [DOI] [PubMed] [Google Scholar]
- 7.Li W, Mei LY, Chen HS, Cai XZ, Liu YL, Men MC, Liu XZ, Yan D, Ling J, Feng Y. New genotypes and phenotypes in patients with 3 subtypes of Waardenburg syndrome identified by diagnostic next-generation sequencing. Neural Plast. 2019;2019:7143458. doi: 10.1155/2019/7143458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cortés-González V, Zenteno JC, Guzmán-Sánchez M, Giordano-Herrera V, Guadarrama-Vallejo D, Ruíz-Quintero N, Villanueva-Mendoza C. Tietz/Waardenburg type 2A syndrome associated with posterior microphthalmos in two unrelated patients with novel MITF gene mutations. Am J Med Genet A. 2016;170(12):3294–3297. doi: 10.1002/ajmg.a.37937. [DOI] [PubMed] [Google Scholar]
- 9.Falzon K, Guerin M, Fulcher T, Viani L. Ophthalmological screening of a paediatric cochlear implant population: a retrospective analysis and 12-year follow-up. Eye (Lond) 2010;24(6):1031–1036. doi: 10.1038/eye.2009.248. [DOI] [PubMed] [Google Scholar]
